Skip to content
  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved

T Cell Engineering: Crafting Cellular Warriors Against Cancer

by Dr. Mehdi Soleymani Goloujeh | October 11th, 2024

Introduction to the Challenge of Cancer Cancer is one of the major global health issues, with its incidence steadily increasing and mortality rates on the rise, affecting millions of people each year. In 2022, approximately 20 million new cancer cases and nearly 9.7 million cancer-related deaths were reported worldwide. By 2050, cancer cases are projected […]

Read More

From Pandemics to Progress: A Survey of Venture Capital Investments in Infectious Disease

by Nicole Tanenbaum | October 11th, 2024

From the blow of the Black Death in medieval Europe, to the polio epidemics of the 20th century, and the widespread devastation caused by smallpox, pathogens have continually caused widespread morbidity and mortality. Today, several of these microbes feel like threats of the past. With advancements in controlling infectious diseases, vaccine-preventable deaths have dropped and […]

Read More

Fermented Fashion

by Alexandra Ramsey | November 24th, 2020

Engaging in constant retail therapy or following the latest fashion trends might soon lead to a bacterial cellulose sweater in your dresser or a pair of mushroom-based Adidas sneakers in your closet. Big-name clothing brands around the world are starting to partner with biotechnology companies, paving the way for a bio-revolution in the textiles industry. […]

Read More

The Challenges of COVID-19 Human Challenge Trials

by Stephanie Holden, PhD | November 23rd, 2020

Would you be willing to voluntarily get infected with a virus for the chance to help advance a vaccine? COVID-19 has killed over a million people worldwide, spurring vaccine development at an unprecedented pace, but for many it still doesn’t feel fast enough. If you’re relatively young and healthy, this may be all the more […]

Read More

Custom nutrition: Are your genes the only diet plan you need?

by Hayley McCausland, BS | August 20, 2020

According to CDC estimates, 139 million American adults (42%) are obese and 34 million Americans have diabetes. Every year, Americans spend upwards of $60 billion on gym memberships, diet plans, and other services dedicated to weight loss. But for many, sticking to a diet is a problem, and for some, knowing where to start can be challenging. Could a personalized diet plan based on genetic testing and real-time monitoring be a helpful tool?

Read More

How telehealth is transforming healthcare in the COVID-19 era

by Nnamdi Nelson, PhD | August 18, 2020

Telehealth has become a broad term used to describe the use of distance telecommunications to deliver medical care, encompassing preventative care, diagnosis, disease management, and patient education.

Read More

Intrapatient Multi-omics: Defining the New Standards in Medicine

by Wadie D. Mahauad-Fernandez, PhD | August 6, 2020

The current model of medicine, which is based on the treatment of diseases via a “one-size-fits-all” approach, is outdated, inefficient, costly, and in some cases harmful. New technological and scientific discoveries have demonstrated that diseases are extremely heterogeneous and vary from one patient to another.

Read More

Sickle cell disease: A case study of systemic racial disparities in US healthcare

by Amy Guo, BS | August 6, 2020

Institutional policies and implicit biases have resulted in neglect at the point of care, higher rates of insurance loss, and a divestment of resources from diseases primarily impacting Black people. These inequities are evident in the past and present state of care in the US for sickle cell disease (SCD), an inherited blood disorder prevalent in those with sub-Saharan African or other malaria-endemic regional ancestry.

Read More

Drug pricing in the US: A Perspective

by Neha P. Paranjape, PhD | June 15, 2020

Despite advances in the drug development process, the price of drugs in the United States continues to rise.

Read More

Recent outbreaks: a focus on COVID-19 and Ebola

by Martina de Majo, PhD | June 9, 2020

Until the 1900s, infectious diseases were responsible for the highest number of deaths worldwide.

Read More

Next »

To learn more about how BCBA can
help your business or organization,
please contact us at info@biotechconnectionbay.org

2025 © Biotech Connection - Bay Area, Inc., All Rights Reserved

Biotech Websites Design by Thomas Digital

  • HOME
  • ABOUT
    • What We Do
    • Team
    • Former Members
    • Community News
  • CONSULTING
    • Projects
    • Example Case Study
    • Consulting FAQs
  • VC
    • Investment Memos
  • COMMUNICATIONS
    • Viewpoints
    • Market Reports
  • EVENTS
  • DIVERSITY
    • Our Statement
    • Action Items
    • Get Involved